{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T10:33:47Z","timestamp":1722162827211},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our aim was to investigate whether receiving a false positive (FP) cervical cytology result affected subsequent cervical cancer screening participation. This Danish nationwide register-based cohort study included 502,380 women aged 22.5\u201345 attending cervical cancer screening in 2012\u20132014 with a normal (n\u2009=\u2009501,003) or FP (n\u2009=\u20091,377) cytology screening result. A FP result was defined as a cervical cytology showing high grade cytological abnormalities followed by a normal or \u2018Cervical Intraepithelial Neoplasia grade 1\u2019 biopsy result. Women were categorized as subsequent participants if they had a cervical cytology within 24\u201342\u00a0months after their last screening or surveillance test. We compared subsequent participation among women with a normal versus a FP result, using odds ratios including 95% confidence intervals. Participation was slightly higher among women with FP results than among women with normal results (71.5% vs. 69.2%, p\u2009=\u20090.058). After adjustment for age and screening history, women with FP results participated significantly more than women with normal results (OR: 1.19, 95% CI 1.06\u20131.35). Women receiving a FP result did not participate less in subsequent cervical cancer screening than women receiving a normal result. In fact, the use of opportunistic screening seemed to be increased among women receiving a FP result.<\/jats:p>","DOI":"10.1038\/s41598-020-72279-x","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T10:04:02Z","timestamp":1600769042000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Screening participation after a false positive result in organized cervical cancer screening: a nationwide register-based cohort study"],"prefix":"10.1038","volume":"10","author":[{"given":"Pernille Thordal","family":"Larsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne Fogh","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Tranberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisse Helle","family":"Njor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"72279_CR1","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/bjc.2014.362","volume":"111","author":"S Vaccarella","year":"2014","unstructured":"Vaccarella, S. et al. 50 years of screening in the Nordic countries: Quantifying the effects on cervical cancer incidence. Br. J. Cancer 111, 965\u2013969. https:\/\/doi.org\/10.1038\/bjc.2014.362 (2014).","journal-title":"Br. J. Cancer"},{"key":"72279_CR2","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","volume":"45","author":"M Arbyn","year":"2009","unstructured":"Arbyn, M., Raifu, A. O., Weiderpass, E., Bray, F. & Anttila, A. Trends of cervical cancer mortality in the member states of the European Union. Eur. J. Cancer 45, 2640\u20132648. https:\/\/doi.org\/10.1016\/j.ejca.2009.07.018 (2009).","journal-title":"Eur. J. Cancer"},{"key":"72279_CR3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1186\/1471-2458-12-992","volume":"12","author":"JA Dickinson","year":"2012","unstructured":"Dickinson, J. A. et al. Reduced cervical cancer incidence and mortality in Canada: National data from 1932 to 2006. BMC Public Health 12, 992. https:\/\/doi.org\/10.1186\/1471-2458-12-992 (2012).","journal-title":"BMC Public Health"},{"key":"72279_CR4","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1002\/ijc.22114","volume":"119","author":"AB Bos","year":"2006","unstructured":"Bos, A. B., Rebolj, M., Habbema, J. D. & van Ballegooijen, M. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int. J. Cancer 119, 2372\u20132375. https:\/\/doi.org\/10.1002\/ijc.22114 (2006).","journal-title":"Int. J. Cancer"},{"key":"72279_CR5","doi-asserted-by":"publisher","first-page":"e0147326","DOI":"10.1371\/journal.pone.0147326","volume":"11","author":"M Rebolj","year":"2016","unstructured":"Rebolj, M. et al. Human papillomavirus assays and cytology in primary cervical screening of women aged 30 years and above. PLoS ONE 11, e0147326. https:\/\/doi.org\/10.1371\/journal.pone.0147326 (2016).","journal-title":"PLoS ONE"},{"key":"72279_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ygyno.2013.11.001","volume":"132","author":"IJ Korfage","year":"2014","unstructured":"Korfage, I. J. et al. How distressing is referral to colposcopy in cervical cancer screening? A prospective quality of life study. Gynecol. Oncol. 132, 142\u2013148. https:\/\/doi.org\/10.1016\/j.ygyno.2013.11.001 (2014).","journal-title":"Gynecol. Oncol."},{"key":"72279_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/j.1600-0412.2003.00165.x","volume":"82","author":"M Idestrom","year":"2003","unstructured":"Idestrom, M., Milsom, I. & Andersson-Ellstrom, A. Women\u2019s experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet. Gynecol. .Scand 82, 756\u2013761. https:\/\/doi.org\/10.1080\/j.1600-0412.2003.00165.x (2003).","journal-title":"Acta Obstet. Gynecol. .Scand"},{"key":"72279_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejca.2009.07.003","volume":"46","author":"IJ Korfage","year":"2010","unstructured":"Korfage, I. J., van Ballegooijen, M., Huveneers, H. & Essink-Bot, M. L. Anxiety and borderline PAP smear results. Eur. J. Cancer 46, 134\u2013141. https:\/\/doi.org\/10.1016\/j.ejca.2009.07.003 (2010).","journal-title":"Eur. J. Cancer"},{"key":"72279_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/pon.2003","volume":"21","author":"M Drolet","year":"2012","unstructured":"Drolet, M. et al. The psychosocial impact of an abnormal cervical smear result. Psychooncology 21, 1071\u20131081. https:\/\/doi.org\/10.1002\/pon.2003 (2012).","journal-title":"Psychooncology"},{"key":"72279_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/aogs.13313","volume":"97","author":"K Pedersen","year":"2018","unstructured":"Pedersen, K. et al. An overview of cervical cancer epidemiology and prevention in Scandinavia. Acta Obstet. Gynecol. Scand. 97, 795\u2013807. https:\/\/doi.org\/10.1111\/aogs.13313 (2018).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"72279_CR11","unstructured":"Dansk Kvalitetsdatabase for Livmoderhalskr\u00e6ftscreening \u00c5rsrapport 2015 [Yearly report from The Danish Quality Database for Cervical Cancer screening]. https:\/\/www.sundhed.dk\/content\/cms\/82\/4682_dkls-%C3%A5rsrapport-2015.pdf."},{"key":"72279_CR12","unstructured":"Screening for livmoderhalskr\u00e6ft\u2014Anbefalinger 2012 [Cervical cancer screening\u2014Recommendations 2012]. https:\/\/www.sst.dk\/~\/media\/B1211EAFEDFB47C5822E883205F99B79.ashx."},{"key":"72279_CR13","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon, D. et al. The 2001 Bethesda system terminology for reporting results of cervical cytology. JAMA 287, 2114\u20132119. https:\/\/doi.org\/10.1001\/jama.287.16.2114 (2002).","journal-title":"JAMA"},{"key":"72279_CR14","unstructured":"Healthcare in Denmark: An Overview. Version 1. edn, (Healthcare Denmark, 2016). https:\/\/www.sum.dk\/English\/~\/media\/Filer%20-%20Publikationer_i_pdf\/2016\/Healthcare-in-dk-16-dec\/Healthcare-english-V16-dec.ashx."},{"key":"72279_CR15","unstructured":"N\u00f8hr, B. et al. Udredning, behandling og kontrol af cervikal dysplasi [Assessment, Treatment and Survaillance of Cervical Dysplasia]. https:\/\/gynobsguideline.dk\/hindsgavl\/Cervixdysplasi2012.pdf."},{"key":"72279_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/00003081-196712000-00002","volume":"10","author":"MR Richart","year":"1967","unstructured":"Richart, M. R. Natural history of cervical intraepithelial neoplasia. Clin. Obstet. Gynecol. 10, 748\u2013784. https:\/\/doi.org\/10.1097\/00003081-196712000-00002 (1967).","journal-title":"Clin. Obstet. Gynecol."},{"key":"72279_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt, M., Pedersen, L. & Sorensen, H. T. The Danish Civil Registration System as a tool in epidemiology. Eur. J. Epidemiol. 29, 541\u2013549. https:\/\/doi.org\/10.1007\/s10654-014-9930-3 (2014).","journal-title":"Eur. J. Epidemiol."},{"key":"72279_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP.S9908","volume":"2","author":"R Erichsen","year":"2010","unstructured":"Erichsen, R. et al. Existing data sources for clinical epidemiology: The Danish National Pathology Registry and Data Bank. Clin. Epidemiol. 2, 51. https:\/\/doi.org\/10.2147\/CLEP.S9908 (2010).","journal-title":"Clin. Epidemiol."},{"key":"72279_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff, M. L. The Danish Cancer Registry. Scand. J. Public Health 39, 42\u201345. https:\/\/doi.org\/10.1177\/1403494810393562 (2011).","journal-title":"Scand. J. Public Health"},{"key":"72279_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge, E., Sandegaard, J. L. & Rebolj, M. The Danish National Patient Register. Scand. J. Public Health 39, 30\u201333. https:\/\/doi.org\/10.1177\/1403494811401482 (2011).","journal-title":"Scand. J. Public Health"},{"key":"72279_CR21","unstructured":"Cancerregistret [The Cancer registry]. https:\/\/sundhedsdatastyrelsen.dk\/da\/registre-og-services\/om-de-nationale-sundhedsregistre\/sygedomme-laegemidler-og-behandlinger\/cancerregisteret (2018)."},{"key":"72279_CR22","unstructured":"SKS klassifikationer [SKS classifications].Sundhedsdatastyrelsen.dk -SKS-total til download. https:\/\/sundhedsdatastyrelsen.dk\/da\/rammer-og-retningslinjer\/om-klassifikationer\/sks-klassifikationer\/download-sks (2018)."},{"key":"72279_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canep.2013.12.007","volume":"38","author":"JH Kristensson","year":"2014","unstructured":"Kristensson, J. H., Sander, B. B., von Euler-Chelpin, M. & Lynge, E. Predictors of non-participation in cervical screening in Denmark. Cancer Epidemiol. 38, 174\u2013180. https:\/\/doi.org\/10.1016\/j.canep.2013.12.007 (2014).","journal-title":"Cancer Epidemiol."},{"key":"72279_CR24","doi-asserted-by":"publisher","first-page":"e0174363","DOI":"10.1371\/journal.pone.0174363","volume":"12","author":"AM Labeit","year":"2017","unstructured":"Labeit, A. M. & Peinemann, F. Determinants of a GP visit and cervical cancer screening examination in Great Britain. PLoS ONE 12, e0174363. https:\/\/doi.org\/10.1371\/journal.pone.0174363 (2017).","journal-title":"PLoS ONE"},{"key":"72279_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1055-9965.Epi-07-2629","volume":"17","author":"GH Rauscher","year":"2008","unstructured":"Rauscher, G. H., Johnson, T. P., Cho, Y. I. & Walk, J. A. Accuracy of self-reported cancer-screening histories: A meta-analysis. Cancer Epidemiol. Biomark. Prev. 17, 748\u2013757. https:\/\/doi.org\/10.1158\/1055-9965.Epi-07-2629 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"72279_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12889-015-1441-y","volume":"15","author":"A Lofters","year":"2015","unstructured":"Lofters, A., Vahabi, M. & Glazier, R. H. The validity of self-reported cancer screening history and the role of social disadvantage in Ontario, Canada. BMC Public Health 15, 28. https:\/\/doi.org\/10.1186\/s12889-015-1441-y (2015).","journal-title":"BMC Public Health"},{"key":"72279_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"AG Ost\u00f6r","year":"1993","unstructured":"Ost\u00f6r, A. G. Natural history of cervical intraepithelial neoplasia: A critical review. Int. J. Gynecol. Pathol. 12, 186\u2013192 (1993).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"72279_CR28","unstructured":"Health Quality Ontario. Women\u2019s experiences of inaccurate breast cancer screening results: A systematic review and qualitative meta-synthesis. Ont. Health Technol. Assess. Ser. 16, 1\u201322 (2016)."},{"key":"72279_CR29","unstructured":"Screening for livmoderhalskr\u00e6ft\u2014Anbefalinger 2018 [Cervical cancer screening-Recommendations 2018]. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2018\/Screening-for-livmoderhalskr%C3%A6ft---anbefalinger-maj-2018.ashx?la=da&hash=65F7E23E37E78D27B8D8683722B7C2DE0697A879."},{"key":"72279_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12889-015-2039-0","volume":"15","author":"M Tranberg","year":"2015","unstructured":"Tranberg, M., Larsen, M. B., Mikkelsen, E. M., Svanholm, H. & Andersen, B. Impact of opportunistic testing in a systematic cervical cancer screening program: A Nationwide Registry Study. BMC Public Health 15, 681. https:\/\/doi.org\/10.1186\/s12889-015-2039-0 (2015).","journal-title":"BMC Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72279-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72279-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72279-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:51:47Z","timestamp":1670356307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72279-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72279"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72279-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MT has participated in previous studies using HPV test kits (CINtec plus kits) sponsored by Roche Diagnostics, Denmark, and HPV self-sampling devices sponsored by Axlab. MT has received speaker\u2019s fees from Astra Zeneca, Denmark, and Roche Diagnostics, Denmark, outside of the submitted work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15427"}}